
doi: 10.1002/ccd.22455
pmid: 20578094
AbstractGranulocyte‐colony stimulating factor (G‐CSF) is commonly used in bone marrow transplant donors to increase the number of circulating progenitor cells. G‐CSF has also been studied following myocardial infarction, but concern has been raised about the risks of G‐CSF administration in patients with coronary artery disease. We present two cases of ischemic cardiac complications that are likely to be related to administration of G‐CSF and provide a contemporary overview of the literature on the cardiovascular risks of G‐CSF. © 2010 Wiley‐Liss, Inc.
Male, Myocardial Ischemia, Coronary Artery Disease, Middle Aged, Hodgkin Disease, Transplantation, Autologous, Hematopoietic Stem Cell Mobilization, Risk Factors, Granulocyte Colony-Stimulating Factor, Humans, Ultrasonography, Interventional, Aged, Bone Marrow Transplantation
Male, Myocardial Ischemia, Coronary Artery Disease, Middle Aged, Hodgkin Disease, Transplantation, Autologous, Hematopoietic Stem Cell Mobilization, Risk Factors, Granulocyte Colony-Stimulating Factor, Humans, Ultrasonography, Interventional, Aged, Bone Marrow Transplantation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 15 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
